A Gene Cluster of Mitochondrial Complexes Contributes to the Cognitive Decline of COVID-19 Infection
Authors:
- 14 September 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (6) , 6869-6883
Abstract
“Brain fog,” a persistent cognitive impairment syndrome, stands out as a significant neurological aftermath of coronavirus disease 2019 (COVID-19). Yet, the underlying mechanisms by which COVID-19 induces cognitive deficits remain elusive. In our study, we observed an upregulation in the expression of genes linked to the inflammatory response and oxidative stress, whereas genes associated with cognitive function were downregulated in the brains of patients infected with COVID-19. Through single-nucleus RNA sequencing (snRNA-seq) analysis, we found that COVID-19 infection triggers the immune responses in microglia and astrocytes and exacerbates oxidative stress in oligodendrocytes, oligodendrocyte progenitors (OPCs), and neurons. Further investigations revealed that COVID-19 infection elevates LUC7L2 expression, which inhibits mitochondrial oxidative phosphorylation (OXPHOS) and suppresses the expression of mitochondrial complex genes such as MT-ND1, MT-ND2, MT-ND3, MT-ND4L, MT-CYB, MT-CO3, and MT-ATP6. A holistic approach to protect mitochondrial complex function, rather than targeting a single molecular, should be an effective therapeutic strategy to prevent and treat the long-term consequences of “long COVID.”Keywords
All Related Versions
Funding Information
- National Science and Technology Innovation 2030 (2022ZD0211804)
- National Natural Science (81870849)
- the Key Research and Development Program of Heilongjiang Province (GA21C009)
This publication has 50 references indexed in Scilit:
- The role of the semaphorins in cancerCell Adhesion & Migration, 2016
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Reactive Oxygen Species in Inflammation and Tissue InjuryAntioxidants & Redox Signaling, 2014
- Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple SclerosisJournal of Neuroscience, 2013
- GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposinProceedings of the National Academy of Sciences, 2013
- Possible roles of DLK1 in the Notch pathway during development and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid-βBrain, 2012
- Hsp90-Cdc37 Chaperone Complex Regulates Ulk1- and Atg13-Mediated MitophagyMolecular Cell, 2011
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- CD45: A Critical Regulator of Signaling Thresholds in Immune CellsAnnual Review of Immunology, 2003